Maud Toulmonde Selected Research

Asthenia

12/2016	Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial.
8/2015	CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maud Toulmonde Research Topics

Disease

25	Sarcoma (Soft Tissue Sarcoma) 01/2024 - 05/2010
22	Neoplasms (Cancer) 01/2024 - 01/2016
6	Disease Progression 01/2023 - 01/2016
6	Neutropenia 01/2022 - 04/2015
4	Neoplasm Metastasis (Metastasis) 01/2022 - 04/2017
4	Fatigue 01/2022 - 04/2015
4	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 08/2019 - 05/2012
3	Tertiary Lymphoid Structures 01/2024 - 01/2021
3	Ewing Sarcoma (Sarcoma, Ewing) 01/2023 - 10/2017
3	Nausea 01/2022 - 01/2017
3	Hypertension (High Blood Pressure) 01/2019 - 01/2016
3	Leiomyosarcoma 04/2017 - 04/2015
3	Thrombocytopenia (Thrombopenia) 01/2017 - 04/2015
2	Brain Diseases (Brain Disorder) 06/2023 - 01/2016
2	Hemangiosarcoma (Angiosarcoma) 05/2023 - 01/2022
2	Aggressive Fibromatosis (Desmoid) 01/2021 - 01/2019
2	Vomiting 01/2021 - 01/2017
2	Osteosarcoma (Osteogenic Sarcoma) 01/2020 - 10/2017
2	Pruritus (Itching) 01/2018 - 08/2015
2	Pigmented Villonodular Synovitis 01/2018 - 08/2015
2	Liposarcoma 10/2017 - 12/2016
2	Febrile Neutropenia 01/2017 - 04/2015
2	Asthenia 12/2016 - 08/2015
1	Amyloidosis 01/2023
1	Breast Neoplasms (Breast Cancer) 12/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2022
1	Alopecia (Baldness) 01/2021
1	Pain (Aches) 01/2021
1	Sarcopenia 12/2020
1	Pneumothorax 01/2020
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2019
1	Dizziness (Lightheadedness) 01/2018
1	Headache (Headaches) 01/2018
1	Anorexia 01/2018
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2018

Drug/Important Bio-Agent (IBA)

7	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 11/2010
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2024 - 10/2022
5	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2020
5	Ifosfamide FDA LinkGeneric 06/2023 - 11/2010
4	Sunitinib (Sutent)FDA Link 08/2019 - 05/2012
4	Imatinib Mesylate (Gleevec)FDA Link 08/2019 - 05/2012
3	TrabectedinIBA 01/2024 - 04/2015
3	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2018
3	AnthracyclinesIBA 01/2021 - 12/2016
3	Biomarkers (Surrogate Marker)IBA 08/2019 - 01/2018
2	avelumabIBA 01/2024 - 01/2022
2	Trinitrotoluene (TNT)IBA 08/2023 - 04/2017
2	pembrolizumabIBA 10/2022 - 01/2020
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022 - 01/2020
2	regorafenibIBA 01/2022 - 12/2016
2	AntibodiesIBA 01/2021 - 01/2018
2	palbociclibIBA 08/2019 - 01/2019
2	pazopanib FDA Link 01/2019 - 01/2016
2	Macrophage Colony-Stimulating FactorIBA 01/2018 - 08/2015
2	Alanine Transaminase (SGPT)IBA 01/2017 - 04/2015
1	Sorafenib (BAY 43-9006)FDA Link 06/2023
1	AntiemeticsIBA 06/2023
1	Aprepitant (Emend)FDA Link 06/2023
1	Vincristine (Oncovin)FDA LinkGeneric 01/2023
1	Etoposide (VP 16)FDA LinkGeneric 01/2023
1	Circulating Tumor DNAIBA 01/2023
1	Insulin (Novolin)FDA Link 01/2023
1	Toll-Like Receptor 4IBA 10/2022
1	PlatinumIBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	Alanine (L-Alanine)FDA Link 01/2022
1	durvalumabIBA 01/2022
1	Dihydrotachysterol (AT 10)IBA 01/2022
1	nintedanibIBA 01/2021
1	erdafitinibIBA 12/2020
1	cyclopropapyrroloindoleIBA 12/2020
1	EnzymesIBA 01/2020
1	atezolizumabIBA 01/2020
1	KynurenineIBA 01/2020
1	CytokinesIBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	cabozantinibIBA 01/2020
1	Tryptophan (L-Tryptophan)FDA Link 01/2020
1	navoximodIBA 01/2020
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2020
1	Vinyl Chloride (Chloroethylene)IBA 01/2019
1	Methotrexate (Mexate)FDA LinkGeneric 01/2019
1	DioxinsIBA 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019
1	Vinblastine (Vinblastine Sulfate)FDA Link 01/2019
1	ChlorophenolsIBA 01/2019
1	tazemetostatIBA 01/2018
1	Lapatinib (GW572016)FDA Link 01/2018
1	Dasatinib (BMS 354825)FDA Link 01/2018
1	Trastuzumab (Herceptin)FDA Link 01/2018

Therapy/Procedure

12	Drug Therapy (Chemotherapy) 05/2023 - 05/2010
9	Therapeutics 01/2024 - 01/2017
3	Immunotherapy 01/2020 - 01/2018
2	Adjuvant Chemotherapy 01/2022 - 01/2018
2	Radiotherapy 02/2021 - 01/2018
2	Combination Drug Therapy (Combination Chemotherapy) 01/2019 - 04/2017
1	Aftercare (After-Treatment) 10/2022
1	Cryosurgery 01/2021
1	Neoadjuvant Therapy 01/2021